⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CDTX News
Cidara Therapeutics, Inc.
Shareholder Alert: The Ademi Firm investigates whether Cidara Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders
prnewswire.com
CDTX
CDTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Cidara Therapeutics, Inc. is Fair to Shareholders
businesswire.com
CDTX
Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent
businesswire.com
MRK
CDTX
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
globenewswire.com
CDTX
Cidara Therapeutics to Participate in November Investor Conferences
globenewswire.com
CDTX
Cidara Therapeutics to Report Third Quarter 2025 Financial Results and Host Quarterly Conference Call on November 6, 2025
globenewswire.com
CDTX
Cidara Therapeutics to Present Late-Breaking Clinical Phase 2 Data on CD388 at ID Week 2025
globenewswire.com
CDTX
Cidara Therapeutics to Present at 10th ESWI Influenza Conference 2025
globenewswire.com
CDTX
Cidara Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for CD388 in Seasonal Influenza Prevention
globenewswire.com
CDTX
Cidara Therapeutics Announces BARDA Award to Support Expanded Manufacturing and Clinical Development of CD388, its Non-Vaccine Influenza Preventative Therapeutic
globenewswire.com
CDTX